This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
HCA Healthcare Q1 Earnings Beat on Growing Patient Volumes
by Zacks Equity Research
HCA continues to witness growth in reported and same-facility admissions. The company reaffirms 2025 guidance.
Compared to Estimates, HCA (HCA) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for HCA (HCA) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
HCA Healthcare (HCA) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of 11.79% and 0.08%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Buy Stock in These Healthcare Leaders as Q1 Earnings Approach? ABBV, HCA
by Shaun Pruitt
The medical sector can provide a defensive hedge against economic uncertainty, and investors may be eyeing AbbVie (ABBV) and HCA Healthcare (HCA) stock ahead of their Q1 reports on Friday, April 25.
HCA Healthcare to Report Q1 Earnings: Key Estimates to Note
by Zacks Equity Research
HCA's first-quarter earnings are likely to have benefited from growing admissions.
Exploring Analyst Estimates for HCA (HCA) Q1 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for HCA (HCA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.
3 Sector ETFs & Stocks to Gain Amid Upbeat March Jobs Data
by Sanghamitra Saha
The March 2025 US jobs report revealed a robust addition of 228,000 jobs, surpassing economists' expectations of 140,000 and the 12-month average of 158,000.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Analyst Blog Highlights Molson Coors, CenterPoint Energy, WEC Energy, Abbott Laboratories and HCA Healthcare
by Zacks Equity Research
Molson Coors, CenterPoint Energy, WEC Energy, Abbott Laboratories and HCA Healthcare are included in this Analyst Blog.
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Take the Zacks Approach to Beat the Markets: PhenixFIN, Palomar, Monster Beverage in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
5 Defensive Stocks to Buy for a Safe Portfolio Amid Tariff-Led Mayhem
by Nalak Das
Five defensive stocks to buy at this soaring volatility are TAP, CNP, WEC, BSX, HCA.
Scoop Up These 3 GARP Stocks to Receive Handsome Returns
by Vasundhara Sawalka
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. HCA, NFG and BGC are some such stocks.
The Zacks Analyst Blog Highlights Mastercard, Medtronic, HCA Healthcare and United Homes
by Zacks Equity Research
Mastercard, Medtronic, HCA Healthcare and United Homes are part of the Zacks top Analyst blog.
Has HCA Healthcare (HCA) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how HCA Healthcare (HCA) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
Top Stock Reports for Mastercard, Medtronic & HCA Healthcare
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including Mastercard Incorporated (MA), Medtronic plc (MDT) and HCA Healthcare, Inc. (HCA), as well as a micro-cap stock United Homes Group, Inc. (UHG).
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Community Health Rides on Same-Store Volumes, Streamlining Efforts
by Zacks Equity Research
With improving labor trends, CYH's contract labor expenses are decreasing.
Tenet Healthcare Gains 26.9% in a Year: Is It the Right Time to Invest?
by Zacks Equity Research
THC benefits from rising admissions, improved payer mix and deleveraging initiatives.
Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Universal Health Stock Down 26.6% in 6 Months: Should You Buy the Dip?
by Zacks Equity Research
UHS' rising admissions and patient days poise its top line well for growth in the future.
Here's Why HCA Healthcare (HCA) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
New to Investing? This 1 Medical Stock Could Be the Perfect Starting Point
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
3 Sector ETFs & Stocks to Gain Despite Downbeat February Jobs Data
by Sanghamitra Saha
These sectors added decent jobs in February when the U.S. economy added fewer-than-expected jobs.